For the best experience, please upgrade to a supported browser:
XLife sciences companies face a range of challenges and opportunities. Our team of industry specialists can help you map out risk strategies and approaches as new issues emerge.
research and briefings
Webcast Replay: our panellists discussed key insurance and risk considerations, whilst detailing current regulation and potential litigation around harmful substances.
Risk in Context
The urgent need to adopt new technologies and ways of working, in order to bring products to market swiftly, could mean that assessing cyber risk is not prioritised, leaving organisations exposed.
Research and Briefings
Our webinar discussed the issues organisations will likely face as they harness new technologies, particularly now that the pandemic has altered the cyber risk landscape for the industry.
Life sciences companies today are faced with a range of challenges. From litigation and the actions of regulators posing a financial and reputational risk, to successful challenges to patents and other forms of intellectual property potentially undermining a firm’s core product and source of revenue. At the same time, insurers are increasingly restricting product liability insurance cover for life sciences companies.
Our understanding of the special risks facing life sciences companies has helped make us one of the leading brokers servicing the sector, giving you access to a creative and expanding range of solutions in pharmaceutical, drug wholesale, nutraceutical, biotechnology, medical device and supply, and contract research. In partnership with our wider network of Marsh & McLennan Companies, we provide solutions and services such as:
Marsh has created centres of excellence to aggregate our knowledge and expertise of the industry, enabling us to keep you abreast of current trends impacting the industry and provide insights in areas of programme design, placement, service, and administration.
By helping reduce your total cost of risk with tailored solutions – insurance brokerage, advisory, and risk management services – Marsh can help you minimise the volatility and severity of risk, protect assets, and maintain profitability.
For clients across the global pharmaceutical industry — biopharma, specialty drugs, generics, animal health, and nutraceuticals — Marsh offers solutions that include:
For clients across the global biotech industry — from large global enterprises to small specialty and "incubator" firms — Marsh offers solutions that include:
For medical device manufacturers, diagnostics companies, and consumer health aid product marketers, Marsh offers solutions that include:
Chrome 38+
Firefox 33+
Microsoft Edge+
